CHE — CHEMED CORP
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 19584 ·
Last close
$541.34
Market Cap
$7.08B
52W High
$556.27
52W Low
$410.48
ADV30
164,386
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 657,513,000 | 215,764,000 | 84,578,000 | 66,302,000 | 1,535,815,000 | 16,856,000 | 687,821,000 |
| Dec 2025 | 639,337,000 | 225,171,000 | 103,563,000 | 76,751,000 | 1,538,189,000 | 74,515,000 | 558,784,000 |
| Sep 2025 | 624,900,000 | 196,907,000 | 74,750,000 | 64,237,000 | 1,623,619,000 | 129,752,000 | 546,936,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$443,747,000
Investing CF
$-83,455,000
Financing CF
$-517,318,000
CapEx
$-66,631,000
Dividends Paid
$-32,543,000
Buybacks
$-588,317,000
EPS Diluted TTM
$19.91
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$3,013,504,000
Inventory
$7,208,000
Receivables
$215,479,000
ST Investments
—
EBIT TTM
$350,877,000
Pretax Income TTM
$348,944,000
Interest Exp TTM
$1,933,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,595,001,088
EBITDA
$416,918,016
Free Cash Flow
$307,859,488
Enterprise Value
$7,300,164,608
Total Cash
$40,222,000
Total Debt
$294,792,992
Shares Out
13,069,961
Trailing EPS
$19.92
Book Value
$63.81
ROE
27.1%
ROA
13.5%
Div Yield
0.52%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,529,978,000 | 341,155,000 | 265,238,000 | 1,538,189,000 | 558,784,000 | — | 388,272,000 |
| Dec 2024 | 2,431,287,000 | 366,939,000 | 301,999,000 | 1,668,575,000 | 549,582,000 | — | 417,497,000 |
| Dec 2023 | 2,264,417,000 | 342,830,000 | 272,509,000 | 1,668,095,000 | 560,219,000 | — | 330,299,000 |
| Dec 2022 | 2,134,963,000 | 347,187,000 | 249,624,000 | 1,442,012,000 | 643,297,000 | — | 309,886,000 |
TTM Snapshot
Revenues TTM
$2,033,144,000
NetIncome TTM
$268,073,000
OpCashFlow TTM
$0
Assets (Latest)
$1,668,575,000
Forward EPS
$27.52
Max Pain — expiry 2027-03-19
max pain strike: $600.00 · spot: $541.33 · call oi: 48 · put oi: 2,519Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PACS | PACS Group, Inc. | $7.00B | $44.25 | — |
| HIMS | Hims & Hers Health, Inc. | $6.99B | $31.08 | — |
| CAI | Caris Life Sciences, Inc. | $7.38B | $26.13 | — |
| RDNT | RadNet, Inc. | $5.88B | $74.69 | — |
| UHS | UNIVERSAL HEALTH SERVICES INC | $9.12B | $176.40 | — |
News headlines (Yahoo Finance, 1h cache)
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
2026-08-14 15:33 · Yahoo
Chemed Corporation Declares Quarterly Dividend of 70 Cents
2026-08-06 15:57 · Yahoo
Chemed (CHE) Deepens Buybacks as Activist Pressure Mounts – What Does This Say About Strategy?
2026-07-30 21:07 · Yahoo
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
2026-07-30 16:45 · Yahoo
Chemed Corp (CHE) Q2 2026 Earnings Call Highlights: Strong Vitas Performance and Strategic ...
2026-07-29 21:05 · Yahoo
Chemed Q2 Earnings Call Highlights
2026-07-29 20:03 · Yahoo
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
2026-07-28 22:00 · Yahoo
Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations
2026-07-28 21:04 · Yahoo
AVAH vs. CHE: Which Stock Should Value Investors Buy Now?
2026-08-05 15:40 · Yahoo
Chemed Corporation Q2 2026 Earnings Call Summary
2026-07-29 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.